GRDX (GridAI Technologies) Tariff Resilience Score: 4/10 (As of Aug. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GRDX GridAI Technologies Corp GRDX
26 GF Score
Price $3.99
! 2 Warning Signs
View Full Analysis

What is GridAI Technologies Tariff Resilience Score?

GridAI Technologies GRDX +1.08% 26 Tariff Resilience Score is 4 as of Aug. 19, 2026. GuruFocus rates GRDX with a GF Score™ of 26/100. The stock has 2 warning signs investors should review. Among 1,362 Biotechnology companies, GridAI Technologies ranks better than 52.72% on this metric.

GridAI Technologies has the Tariff Resilience Score of 4, which implies that the company might have Average Resilient.

GridAI Technologies has Entero Therapeutics is vulnerable due to its reliance on imported raw materials for drug development. The company has limited pricing power and few alternative suppliers, making it susceptible to tariff fluctuations.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes GridAI Technologies might have Average Resilient.

GridAI Technologies  (NAS:GRDX) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

GridAI Technologies Tariff Resilience Score Related Terms

GRDX vs CELU, NRSN, ZIVO: Tariff Resilience Score Comparison

For the Biotechnology subindustry, GridAI Technologies's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GridAI Technologies Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GridAI Technologies's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where GridAI Technologies's Tariff Resilience Score falls into.


GRDX
26GF Score
GridAI Technologies Corp GRDX
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 4 mean?
GridAI Technologies (GRDX) has a Tariff Resilience Score of 4 as of Aug. 19, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, GridAI Technologies ranks #644 out of 1362 companies in the Biotechnology industry, placing it in the top 47.3%.
Is GridAI Technologies' Tariff Resilience Score too high?
GridAI Technologies' current Tariff Resilience Score is 4. The Biotechnology industry median Tariff Resilience Score is 4.00. GridAI Technologies' value of 4 is 0% at this industry median. Based on the distribution chart, GridAI Technologies ranks #644 out of 1362 companies in the Biotechnology industry, which is above the industry midpoint. Overall, GridAI Technologies has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does GridAI Technologies' Tariff Resilience Score compare to CELU and NRSN?
According to the Biotechnology industry distribution chart, GridAI Technologies ranks #644 out of 1362 companies for Tariff Resilience Score. This puts GridAI Technologies in the upper half of its industry. The industry median Tariff Resilience Score is 4.00. GridAI Technologies' value of 4 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,362 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GridAI Technologies's current Tariff Resilience Score of 4 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GridAI Technologies's current Tariff Resilience Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GridAI Technologies stock overvalued right now?
GridAI Technologies (GRDX) has a current Tariff Resilience Score of 4. The current Tariff Resilience Score is 4 and 0% at the Biotechnology industry median of 4.00. GridAI Technologies' overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For GridAI Technologies (GRDX), the current Tariff Resilience Score is 4 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GridAI Technologies Business Description

Address 433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
26GF Score

Get the complete analysis for GRDX

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.99
Price